ActiveAtlas Opportunity Score 91/100
HT942523SBAA1
Defense Health Agency – Extramural Medical Research Broad Agency Announcement (HT942523SBAA1)
Continuously open Defense Health Agency and USAMRDC broad agency announcement for extramural medical research through September 30, 2027 at 11:59 PM Eastern Time. Atlas identifies a strong conditional fit for the Nonagon N9+ device and platform under virtual health and monitoring, telemedicine, physiological monitoring, scalable triage, and related combat casualty care research.
FundingNo fixed total funding amount or predetermined number of awards is stated. Awards depend on available funds, scientific and technical merit, and programmatic priorities.
DeadlineSeptember 30, 2027 at 11:59 PM Eastern Time. The BAA is continuously open before this close.
Last verifiedOctober 4, 2026
Required next actionDefine a specific military-health research hypothesis and technical aims, confirm alignment with an active BAA research area, verify the qualified PI/team and required registrations, address FDA/regulatory and human-subject obligations as applicable, and submit the required first-stage pre-proposal through eBRAP. Advance to a full proposal only if invited under the BAA.
Broad Eligibility
Eligible extramural organizations may include national or international for-profit, nonprofit, public, and private organizations; awards are not made to individuals. Full eligibility and registration requirements depend on the proposed effort and award instrument.
Atlas Analysis
Atlas Opportunity Score 94/100. The DHA extramural medical research BAA is a continuously open broad agency announcement through September 30, 2027 for meritorious military-health research and development concepts within the listed research areas. Fit depends on a clearly defined military-health problem, research readiness, qualified investigators, applicable regulatory and human-subject requirements, and alignment with the BAA's technical areas. Do not infer eligibility or submission readiness from topic relevance alone.
The U.S. Department of Defense, Defense Health Agency and U.S. Army Medical Research and Development Command are accepting extramural medical research ideas under HT942523SBAA1, the FY23-FY27 Broad Agency Announcement for Extramural Medical Research.
Deadline: The BAA is continuously open through September 30, 2027 at 11:59 PM Eastern Time. Pre-proposals may be submitted before the close, subject to the BAA requirements and available funding.
Funding: The BAA does not establish a fixed total funding amount or predetermined number of awards. Awards depend on available funds, scientific and technical merit, and programmatic priorities. Cost sharing is generally not required, although alternative instruments such as OTAs or TIAs may have different requirements.
Eligibility: Eligible extramural organizations may include national or international for-profit, nonprofit, public, and private organizations. Awards are not made to individuals. Applicants must satisfy the registrations, representations, and other requirements applicable to the selected award instrument.
Submission process: This is a two-stage process. Applicants first submit a specific research pre-proposal or pre-application through eBRAP. Only invited applicants proceed to a full proposal or application through Grants.gov. The first-stage submission must present a defined research idea rather than a general capability statement.
N9+ fit: Atlas rates the Nonagon N9+ device and platform at 91/100 for this BAA, conditional on a specific military-health research hypothesis and an operationally credible use case. The BAA’s Virtual Health and Monitoring capability area expressly includes telemedicine, enhanced assessment and diagnosis, continued physiological or injury-status monitoring, provider decision support, scalable triage, and related technologies. A credible N9+ project would still need to establish military relevance, research aims, technical readiness, qualified investigators, regulatory and human-subjects requirements where applicable, and cybersecurity, connectivity, DDIL, or tactical integration requirements relevant to the proposed setting.
Atlas Opportunity Score: 94/100. Atlas classifies this as a high-priority direct Dr. Miltie/QC Healthcare opportunity for review, not an automatic submission. No award, eligibility determination, regulatory outcome, or military suitability is implied.
Official source: Defense Health Agency / USAMRDC BAA HT942523SBAA1.
From Funding to Implementation · Virtual Care Solution
Give technology funding a clinically meaningful use case.
Dr. Miltie N9+ supports up to nine clinician-directed remote examinations and connected-care workflows, helping organizations move from generic telehealth infrastructure toward a more complete virtual exam model.
Source verificationOfficial government source · files.simpler.grants.govAtlas last verified this record October 4, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
